🔎 Trials Near Me

홈 › 연부조직 육종 › 텍사스

텍사스의 연부조직 육종 임상 시험

연부조직 육종 관련 연구 37개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

  • UT MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06498648

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
  • Baylor College of Medicine, Houston
피험자 모집 중1/2상
25세 이하 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04094610

DESTINY-PANTUMOUR04

  • Research Site, Dallas
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Anti-GD2 ADC M3554 in Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06641908

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07705334

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

  • University Of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06797999

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT05732831

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • UT MD Anderson Cancer Center, Houston
피험자 모집 중1상
12세 ~ 85세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT03715933

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

  • UT MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT05711615

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06760819

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • UT MD Anderson Cancer Center, Houston
  • Audie L Murphy VA Hospital, San Antonio
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Actinium Therapy for Late-stage Aggressive Sarcomas

  • MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07156565

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  • MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
  • NEXT Dallas, Irving
  • 외 2개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06975293

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

  • M D Anderson Cancer Center, Houston
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT01772771

Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

  • MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07283731

T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.

  • MD Anderson Cancer Center, Houston
피험자 모집 중1상
12세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06474676

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

  • Ut Southwestern Medical Center, Dallas
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT07139990

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

  • M D Anderson Cancer Center, Houston
피험자 모집 중
10세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT04199026

A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas

  • The University of Texas M. D. Anderson Cancer Center, Houston
피험자 모집 중1상
1세 ~ 30세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07444619

IDOV-Immune for Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
  • South Texas Accelerated Research Therapeutics, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06910657

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

  • MD Anderson Cancer Center, Houston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 7. 15. 업데이트됨 · NCT07377747

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 ~ 90세 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT06710756

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

  • M D Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT04771520

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

  • MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT06789172

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • UT Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT03093116

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

  • M.D. Anderson Children's Cancer Hospital, Houston
피험자 모집 중2상
8세 ~ 30세 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT05726383

SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

  • The University of Texas M. D. Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT07049848

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

  • University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT04969835

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

  • William Beaumont Army Medical Center, Fort Bliss
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT06129903

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

  • M D Anderson Cancer Center, Houston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT04693377

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Children's Health Dallas, Dallas
  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
2세 ~ 30세 · 모든 성별 · 2026. 2. 3. 업데이트됨 · NCT05734066

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

  • Texas Children's Hospital, Houston
피험자 모집 중1상
1세 ~ 25세 · 모든 성별 · 2026. 1. 22. 업데이트됨 · NCT04995003

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Elligo Health Research, Inc., Austin
피험자 모집 중관찰 연구건강한 지원자 환영
40세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT05366881

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 12. 11. 업데이트됨 · NCT06943521

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

  • Mary Crowley Cancer Research, Dallas
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 10. 8. 업데이트됨 · NCT04370587

BostonGene and Exigent Genomic INsight Study

  • Oncology Consultants, Houston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 2. 17. 업데이트됨 · NCT06272864

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.